Sort
35,931 grants matching “parkinsons”
Adminstration
$548,912Dennis William Dickson · Mayo Clinic Jacksonville · P50 · FY2010 · NS
Chaperone Protein and Protein Conformational Switches
$548,679Susan L. Lindquist · Whitehead Institute For Biomedical Res · R01 · FY2010 · GM
High Resolution Manometry: A Novel Pattern Recognition Method for Dysphagia
$548,606Timothy M McCulloch · University Of Wisconsin-Madison · R33 · FY2013 · DC
High Resolution Manometry: A Novel Pattern Recognition Method for Dysphagia
$548,606Timothy M McCulloch · University Of Wisconsin-Madison · R33 · FY2014 · DC
Role of meningeal lymphatic vasculature in neuroimmune communication development
$548,579Jean-Leon Thomas · Yale University · R01 · FY2024 · NS
Community Engagement Core
$548,462Omrana Pasha-Razzak · City College Of New York · U54 · FY2025 · MD
Role of PERK haplotypes in HIV-Associated Neurocognitive Disorders
$548,434Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2017 · MH
Efficacy of Voice Treatment for Parkinson's Disease
$548,390University Of Colorado At Boulder · R01 · FY2005 · DC
Comprehensive MRI Guidance of Focused Ultrasound Neurosurgery
$548,335Craig H Meyer · University Of Virginia · R01 · FY2022 · EB
Apoptosis In Neurodegenerative Disorders
$548,307Mark Mattson · National Institute On Aging · ZIA · FY2018 · AG
Resilience, Dysregulation, and Rescue of Basal Ganglia Indirect Pathway Function in Progressive Parkinsonism
$548,208Mark D Bevan · Northwestern University At Chicago · R01 · FY2024 · NS
Characterizing Alzheimer's Disease with INSPECDS: Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes
$548,140Chris Berka · Advanced Brain Monitoring, Inc. · R44 · FY2018 · AG
An ODNP Probe to Study Hydration Dynamics in Membrane Protein
$547,902Thorsten Maly · Bridge 12 Technologies, Inc. · R44 · FY2020 · GM
Assessment of Candidate Loci in Neurological diseases
$547,869Andrew Singleton · National Institute On Aging · ZIA · FY2020 · AG
Repurposing FDA-approved agonists of HCAR2 as novel therapeutics for Alzheimer's Disease
$547,852Gary E. Landreth · Indiana University Indianapolis · R01 · FY2025 · AG
Clinical Core B
$547,824Daniel Weintraub · University Of Pennsylvania · U19 · FY2019 · AG
Clinical Core B
$547,823Daniel Weintraub · University Of Pennsylvania · U19 · FY2020 · AG
Sensory pathways for stimulus detection during behavior
$547,750Manuel A Castro-Alamancos · Drexel University · R35 · FY2020 · NS
Therapeutic evaluation of targeting Tau Tubulin kinase-1 in Alzheimerâs disease
$547,750Seiko Ikezu · Mayo Clinic Jacksonville · R01 · FY2024 · AG
Therapeutic evaluation of targeting Tau Tubulin kinase-1 in Alzheimerâs disease
$547,750Seiko Ikezu · Mayo Clinic Jacksonville · R01 · FY2023 · AG
Sensory pathways for stimulus detection during behavior
$547,750Manuel A Castro-Alamancos · University Of Connecticut Sch Of Med/Dnt · R35 · FY2023 · NS
Nonrecurrent rearrangements, genome architecture and neurodegenerative disease.
$547,750James R. Lupski · Baylor College Of Medicine · R01 · FY2011 · NS
Sensory pathways for stimulus detection during behavior
$547,750Manuel A Castro-Alamancos · University Of Connecticut Sch Of Med/Dnt · R35 · FY2021 · NS
Sensory pathways for stimulus detection during behavior
$547,750Manuel A Castro-Alamancos · University Of Connecticut Sch Of Med/Dnt · R35 · FY2022 · NS
Sensory pathways for stimulus detection during behavior
$547,750Manuel A Castro-Alamancos · Drexel University · R35 · FY2019 · NS